Skip to main navigation Skip to search Skip to main content

Chronic Cholestatic Liver Injury Attributable to Vedolizumab

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)277-280
JournalJournal of Clinical and Translational Hepatology
Volume4
Issue number3
StatePublished - Sep 28 2016

Cite this